JP2023544614A5 - - Google Patents

Info

Publication number
JP2023544614A5
JP2023544614A5 JP2023521190A JP2023521190A JP2023544614A5 JP 2023544614 A5 JP2023544614 A5 JP 2023544614A5 JP 2023521190 A JP2023521190 A JP 2023521190A JP 2023521190 A JP2023521190 A JP 2023521190A JP 2023544614 A5 JP2023544614 A5 JP 2023544614A5
Authority
JP
Japan
Prior art keywords
seq
antigen
sequence
amino acid
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023521190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544614A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/051160 external-priority patent/WO2022073062A1/en
Publication of JP2023544614A publication Critical patent/JP2023544614A/ja
Publication of JP2023544614A5 publication Critical patent/JP2023544614A5/ja
Pending legal-status Critical Current

Links

JP2023521190A 2020-10-05 2021-10-05 Clec9a抗体 Pending JP2023544614A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020903586 2020-10-05
AU2020903586A AU2020903586A0 (en) 2020-10-05 Clec9A antibodies
PCT/AU2021/051160 WO2022073062A1 (en) 2020-10-05 2021-10-05 Clec9a antibodies

Publications (2)

Publication Number Publication Date
JP2023544614A JP2023544614A (ja) 2023-10-24
JP2023544614A5 true JP2023544614A5 (enExample) 2024-10-18

Family

ID=81127084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521190A Pending JP2023544614A (ja) 2020-10-05 2021-10-05 Clec9a抗体

Country Status (6)

Country Link
US (1) US20230374142A1 (enExample)
EP (1) EP4225795A4 (enExample)
JP (1) JP2023544614A (enExample)
CN (1) CN116547003A (enExample)
AU (1) AU2021356294A1 (enExample)
WO (1) WO2022073062A1 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426565B2 (en) * 2007-08-30 2013-04-23 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
US20110110861A1 (en) * 2008-05-13 2011-05-12 Mireille Hanna Lahoud Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
CA2755983A1 (en) * 2009-03-23 2010-09-30 The Walter And Eliza Hall Institute Of Medical Research Compounds and methods for modulating an immune response
EP3576782A4 (en) * 2017-02-02 2020-12-30 Silverback Therapeutics, Inc. COMPOSITIONS OF RECOMBINATION PRODUCT-PEPTIDE AND THEIR METHODS OF USE
KR20220007584A (ko) * 2019-02-11 2022-01-18 주무토르 바이오로직스 인코포레이티드 항-clec2d 항체 및 이의 사용 방법
US12351614B2 (en) * 2019-03-28 2025-07-08 Orionis Biosciences, Inc. CLEC9A-based chimeric protein complexes

Similar Documents

Publication Publication Date Title
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
AU2017237543B2 (en) Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus, and use for same
CN107405397B (zh) 抗tim-3抗体
AU2019412754B2 (en) BTN3A binding proteins and uses thereof
WO2021027674A1 (zh) 一种含有抗体的肿瘤治疗剂的开发和应用
JP6421371B2 (ja) トランスポーターに対する抗体およびその用途
CN107438621A (zh) 抗pd‑1抗体
JP2012518425A5 (enExample)
CN114502591A (zh) 靶向bcma的抗体、双特异性抗体及其用途
JP2023540526A5 (enExample)
JP7851923B2 (ja) インターロイキン1アルファに特異的な真のヒト抗体
JP7830445B2 (ja) インターロイキン1アルファに特異的な真のヒト抗体
CN106243223B (zh) 抗人pdl1抗体及其用途
KR20230117183A (ko) 새로운 종양 인게이저 치료 약물의 개발 및 이의 용도
WO2022267936A1 (zh) 特异性结合糖基化ceacam5的抗体
CN111518208A (zh) 抗cd47抗体及其应用
JP2023544614A5 (enExample)
JP7641292B2 (ja) 抗cd19抗体、その使用方法及び製造方法
JP2024536358A5 (enExample)
JP2023536630A5 (enExample)
CN114729057A (zh) 抗岩藻糖基-gm1抗体
US12331133B2 (en) Therapeutic antibodies for treating lung cancer
JP2011024537A (ja) トランスポーターに対する抗体およびその用途
EP4183800A1 (en) Novel sars-cov-2 neutralizing antibodies
HK40112840A (zh) 抗cd19抗体及其使用和制备方法